Impact of the Oncotype DX breast cancer assay on treatment decisions in a UK population of patients with oestrogen receptor positive early breast cancer with 1-3 lymph nodes positive who are candidates for chemotherapy, but for whom the benefits are uncertain - Interim results - Bournemouth University Staff Profile Pages

Impact of the Oncotype DX breast cancer assay on treatment decisions in a UK population of patients with oestrogen receptor positive early breast cancer with 1-3 lymph nodes positive who are candidates for chemotherapy, but for whom the benefits are uncertain - Interim results

Authors: Thomas, D., Maxwell, W., Archer, C., Rigg, A., Hickish, T., Dent, J., Pettit, L., Dillon, M., Goldsmith, C., Verrill, M., Barthelmes, L., Khawaja, S., Sharaiha, Y., Davies, M., Arikat, F., Khan, S., Munir, A., Huws, A., Holt, S.D.

Journal: CANCER RESEARCH

Publication Date: 02/2020

Volume: 80

Issue: 4

eISSN: 1538-7445

ISSN: 0008-5472

DOI: 10.1158/1538-7445.SABCS19-OT3-17-03

Source: Web of Science